血管周细胞在肿瘤血管生成和转移过程中的作用研究进展

邓鑫; 罗茂; 李蓉; 吴剑波

doi:10.3969/j.issn.1000-8179.2013.08.013

血管周细胞在肿瘤血管生成和转移过程中的作用研究进展

doi: 10.3969/j.issn.1000-8179.2013.08.013

泸州医学院药物与功能性食品研究中心（四川省泸州市646000）

基金项目:

国家自然科学基金 81172050

详细信息

通讯作者:
吴剑波 jbwucn@163.com

计量
- 文章访问数: 6
- HTML全文浏览量: 0
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2012-07-30
- 修回日期: 2012-09-24

Role of pericytes during tumor angiogenesis and metastasis

Drugs and Functional Food Research Center, Luzhou Medical College, Luzhou 64600, China

Funds:

the National Natural Science Foundation of China 81172050

More Information

Corresponding author: Jianbo WU; E-mail: jbwucn@163.com

摘要

摘要: 大量研究证明肿瘤的生长和转移与肿瘤血管生成密切相关。血管周细胞作为血管组织的重要组成部分, 在血管新生以及维持血管稳定中发挥重要作用。作为一种血管周基质细胞, 血管周细胞能为血管提供结构支持以及通过影响血管稳定性来调整局部组织生理环境。尽管目前血管周细胞在癌症病理机制中的作用还不完全清楚, 但大量研究结果揭示血管周细胞-内皮细胞信号网络的失常对肿瘤血管生成和转移有重要意义。本文旨在评价关于血管周细胞在肿瘤病理机制方面的重要研究成果以及探讨潜在的抗癌治疗靶点。
- 血管周细胞 /
- 血管生成 /
- 肿瘤转移
Abstract: A large number of studies have demonstrated that the growth and metastasis of tumors are closely correlated with tumor angiogenesis.Pericytes are an important part of the vascular tissues, which play a significant role in angiogenesis and vascular stability.As perivascular stromal cells, pericytes can provide structural support to the blood vessels and regulate local physiological environment via its influence on the vascular stability.Although the functional role of pericytes in cancer progression remains unclear, numerous studies have indicated that the aberrations in the pericyte–endothelial cell signaling networks could contribute significantly on tumor angiogenesis and metastasis.This review aims to critically evaluate the results of a recent study on the functional role of pericytes in tumor pathophysiology and discuss potential therapeutic targets for anticancer intervention.
- pericytes /
- angiogenesis /
- tumor metastasis

HTML全文

参考文献(25)

[1]	阎锡蕴. 肿瘤新生血管及分子靶向治疗新策略[J]. 生物物理学报, 2010, 26(3): 180-193. https://www.cnki.com.cn/Article/CJFDTOTAL-SWWL201003007.htm
[2]	Shibuya M. Vascular Endothelial Growth Factor(VEGF)and Its Receptor(VEGFR)Signaling in Angiogenesis: A Crucial Targetfor Anti-and Pro-Angiogenic Therapies[J]. Genes Cancer, 2011, 2(12): 1097-1105. doi: 10.1177/1947601911423031
[3]	Felcht M, Luck R, Schering A, et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling[J]. JClin Invest, 2012, 122(6): 1991-2005. doi: 10.1172/JCI58832
[4]	Lau LF. CCN1 and CCN2: blood brothers in angiogenic action[J]. J Cell Commun Signal, 2012, 6(3): 121-123. doi: 10.1007/s12079-012-0169-z
[5]	Franco M, Roswall P, Cortez E, et al. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-wexpression[J]. Blood, 2011, 118(10): 2906-2917. doi: 10.1182/blood-2011-01-331694
[6]	Shibuya M. Vascular Endothelial Growth Factor(VEGF)and Its Receptor(VEGFR)Signaling in Angiogenesis: A Crucial Targetfor Anti-and Pro-Angiogenic Therapies[J]. Genes Cancer, 2011, 2(12): 1097-1105. doi: 10.1177/1947601911423031
[7]	Chantrain CF, Henriet P, Jodele S, et al. Mechanisms of pericyte re cruitment in tumour angiogenesis: a new role for metalloproteinases[J]. Eur J Cancer, 2006, (3): 310-318.
[8]	Raica M, Cimpean AM. Platelet-derived growth factor(PDGF)/PDGF receptors(PDGFR)axis as target for antitumor and antian giogenic therapy[J]. Pharmaceuticals, 2010, 3(3): 572-599. doi: 10.3390/ph3030572
[9]	Jodele S, Chantrain CF, Blavier L, et al. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrixmetalloproteinase-9 dependent[J]. Cancer Res, 2005, 65(8): 3200-3208. doi: 10.1158/0008-5472.CAN-04-3770
[10]	Saunders WB, Bohnsack BL, Faske JB, et al. Coregulation of vascu lar tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3[J]. J Cell Biol, 2006, 175(1): 179-191. doi: 10.1083/jcb.200603176
[11]	Stratman AN, Malotte KM, Mahan RD, et al. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrixformation[J]. Blood, 2009, 114(24): 5091-5101. doi: 10.1182/blood-2009-05-222364
[12]	Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendo thelial sources of PDGF-B regulate pericyte recruitment and influ ence vascular patternformation in tumors[J]. J Clin Invest, 2003, 112(8): 1142-1151. doi: 10.1172/JCI200318549
[13]	Bjarneg rd M, Enge M, Norlin J, et al. Endothelium-specific abla tion of PDGFB leads to pericyte loss and glomerular, cardiac and placentalabnormalities[J]. Development, 2004, 131(8): 1847-1857. doi: 10.1242/dev.01080
[14]	Lindblom P, Gerhardt H, Liebner S, et al. Endothelial PDGF-B re tention is required for proper investment of pericytes in the mi crovessel wall[J]. Genes Dev, 2003, 17(15): 1835-1840. doi: 10.1101/gad.266803
[15]	何胜利, 高勇, 刘道永, 等. Ang-1、Ang-2和Tie2表达与肝癌血管生成的关系[J]. 临床肿瘤学杂志, 2009, 14(5): 439-442. doi: 10.3969/j.issn.1009-0460.2009.05.014
[16]	Huang H, Lai JY, Do J, et al. Specifically targeting angiopoietin-2inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumorgrowth[J]. Clin Cancer Res, 2011, 17(5): 1001-1011. doi: 10.1158/1078-0432.CCR-10-2317
[17]	Huang FJ, You WK, Bonaldo P, et al. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse[J]. Dev Biol, 2010, 344(2): 1035-1046. doi: 10.1016/j.ydbio.2010.06.023
[18]	Cooke VG, LeBleu VS, Keskin D, et al. Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway[J]. Cancer Cell, 2011, 21: 66-81.
[19]	Welén K, Jennbacken K, Tesan T, et al. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xeno grafts[J]. Prostate Cancer Prostatic Dis, 2009, 12(1): 41-46. doi: 10.1038/pcan.2008.33
[20]	Decker NK, Abdelmoneim SS, Yaqoob U, et al. Nitric oxide regu lates tumor cell cross-talk with stromal cells in the tumor microen vironment of the liver[J]. Am J Pathos 2008, 173(4): 1002-1012.
[21]	Vidal-Vanaclocha F. The prometastatic microenvironment of the liver[J]. Cancer Microenviron, 2008, 1(1): 113-129. doi: 10.1007/s12307-008-0011-6
[22]	陈旭升, 孙丹, 姚欣. PDGF和PDGFR与肿瘤的关系及其靶向治疗研究进展[J]. 中国肿瘤临床, 2012, 39(15): 1134-1137. doi: 10.3969/j.issn.1000-8179.2012.15.035
[23]	Lu C, Shahzad MM, Moreno-Smith M, et al. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models[J]. Cancer Biol Ther, 2010, 9(3): 176-182. doi: 10.4161/cbt.9.3.10635
[24]	方兴根, 赵瑞, 王奎重, 等. 内皮祖细胞参与兔动脉瘤模型血管的修复[J]. 中国脑血管病杂志, 2011, 8(6): 318-322. doi: 10.3969/j.issn.1672-5921.2011.06.009
[25]	Katare R, Riu F, Mitchell K, et al. Transplantation of human peri cyte progenitor cells improves the repair of infarcted heart through activation of anangiogenic program involving micro-RNA-132[J]. Circ Res, 2011, 109(8): 894-906. doi: 10.1161/CIRCRESAHA.111.251546